Improvement of SARS-CoV-2 symptoms following Guselkumab injection in a psoriatic patient

被引：27
作者：
Benhadou, F. [1 ]
del Marmol, V. [1 ]
机构：
[1] Univ Libre Bruxelles, Dept Dermatol, Erasme Hosp, Brussels, Belgium
来源：
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY | 2020年 / 34卷 / 08期
关键词：
COVID-19; EFFICACY; MODERATE; SAFETY;
D O I：
10.1111/jdv.16590
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：E363 / E364
页数：2
相关论文
共 7 条
  • [1] Efficacy and safety of ixekizumab for the treatment of moderate-to-severe plaque psoriasis: Results through 108 weeks of a randomized, controlled phase 3 clinical trial (UNCOVER-3)
    Blauvelt, Andrew
    Gooderham, Melinda
    Iversen, Lars
    Ball, Susan
    Zhang, Lu
    Agada, Noah O.
    Reich, Kristian
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2017, 77 (05) : 855 - 862
  • [2] Efficacy and safety of guselkumab, an anti-interleukin-23 monoclonal antibody, compared with adalimumab for the continuous treatment of patients with moderate to severe psoriasis: Results from the phase III, double-blinded, placebo- and active comparatore-controlled VOYAGE 1 trial
    Blauvelt, Andrew
    Papp, Kim A.
    Griffiths, Christopher E. M.
    Randazzo, Bruce
    Wasfi, Yasmine
    Shen, Yaung-Kaung
    Li, Shu
    Kimball, Alexa B.
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2017, 76 (03) : 405 - 417
  • [3] Reply to: "COVID-19, syphilis, and biologic therapies for psoriasis and psoriatic arthritis: A word of caution''
    Lebwohl, Mark
    Rivera-Oyola, Ryan
    Murrell, Dedee F.
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2020, 82 (06) : E215 - E215
  • [4] COVID-19: consider cytokine storm syndromes and immunosuppression
    Mehta, Puja
    McAuley, Daniel F.
    Brown, Michael
    Sanchez, Emilie
    Tattersall, Rachel S.
    Manson, Jessica J.
    [J]. LANCET, 2020, 395 (10229) : 1033 - 1034
  • [5] SARS-CoV-2 infection in a psoriatic patient treated with IL-23 inhibitor
    Messina, F.
    Piaserico, S.
    [J]. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2020, 34 (06) : E254 - E255
  • [6] COVID-19: risk for cytokine targeting in chronic inflammatory diseases?
    Schett, Georg
    Sticherling, Michael
    Neurath, Markus F.
    [J]. NATURE REVIEWS IMMUNOLOGY, 2020, 20 (05) : 271 - 272
  • [7] In the eye of the COVID-19 cytokine storm
    Vaninov N.
    [J]. Nature Reviews Immunology, 2020, 20 (5) : 277 - 277
1